J.Chris Jensen

1.3k total citations
24 papers, 1.0k citations indexed

About

J.Chris Jensen is a scholar working on Oncology, Pharmacology and Infectious Diseases. According to data from OpenAlex, J.Chris Jensen has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Pharmacology and 5 papers in Infectious Diseases. Recurrent topics in J.Chris Jensen's work include Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Alcohol Consumption and Health Effects (4 papers). J.Chris Jensen is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Alcohol Consumption and Health Effects (4 papers). J.Chris Jensen collaborates with scholars based in Germany, United States and Denmark. J.Chris Jensen's co-authors include R Gugler, Morris D. Faiman, Michel Eichelbaum, Roy B. Lacoursiere, U. Loos, E. Musch, M. B. Thoefner, Sandra M. Frei, Stine Jacobsen and Gerd Mikus and has published in prestigious journals such as Gastroenterology, American Journal of Psychiatry and Pharmacology & Therapeutics.

In The Last Decade

J.Chris Jensen

24 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.Chris Jensen Germany 16 334 226 218 172 172 24 1.0k
X.-J. Zhao United States 11 342 1.0× 204 0.9× 234 1.1× 160 0.9× 339 2.0× 16 1.0k
H Laufen Germany 22 176 0.5× 186 0.8× 470 2.2× 325 1.9× 365 2.1× 76 1.5k
Geoffrey Warhurst United Kingdom 22 125 0.4× 274 1.2× 297 1.4× 86 0.5× 171 1.0× 34 1.4k
F A deLuna United States 15 166 0.5× 292 1.3× 108 0.5× 130 0.8× 218 1.3× 24 844
Keith Hoffmaster United States 16 409 1.2× 625 2.8× 114 0.5× 100 0.6× 154 0.9× 20 1.4k
Sou-Yie Chu United States 14 93 0.3× 91 0.4× 260 1.2× 260 1.5× 127 0.7× 24 668
Hugues Chanteux Belgium 17 276 0.8× 238 1.1× 210 1.0× 308 1.8× 157 0.9× 39 1.7k
Steven R. Cox United States 15 154 0.5× 134 0.6× 39 0.2× 196 1.1× 49 0.3× 35 714
Niklas Finnström Sweden 13 250 0.7× 246 1.1× 382 1.8× 48 0.3× 400 2.3× 20 939
R A Yeates Germany 16 125 0.4× 103 0.5× 182 0.8× 85 0.5× 251 1.5× 35 692

Countries citing papers authored by J.Chris Jensen

Since Specialization
Citations

This map shows the geographic impact of J.Chris Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.Chris Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.Chris Jensen more than expected).

Fields of papers citing papers by J.Chris Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.Chris Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.Chris Jensen. The network helps show where J.Chris Jensen may publish in the future.

Co-authorship network of co-authors of J.Chris Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of J.Chris Jensen. A scholar is included among the top collaborators of J.Chris Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.Chris Jensen. J.Chris Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobsen, Stine, J.Chris Jensen, Sandra M. Frei, A. L. Jensen, & M. B. Thoefner. (2005). Use of serum amyloid A and other acute phase reactants to monitor the inflammatory response after castration in horses: a field study. Equine Veterinary Journal. 37(6). 552–556. 93 indexed citations
2.
Jensen, J.Chris. (1990). Pharmacokinetics of Lamisil® in humans. Journal of Dermatological Treatment. 1(sup2). 15–18. 40 indexed citations
3.
Eichelbaum, Michel, et al.. (1989). Antipyrine metabolism is not affected by terbinafine, a new antifungal agent. European Journal of Clinical Pharmacology. 37(3). 231–233. 21 indexed citations
4.
Jensen, J.Chris. (1989). Clinical pharmacokinetics of terbinafine (Lamisil). Clinical and Experimental Dermatology. 14(2). 110–113. 102 indexed citations
5.
Loos, U., et al.. (1987). Influence of the enzyme induction by rifampicin on its presystemic metabolism. Pharmacology & Therapeutics. 33(1). 201–204. 19 indexed citations
6.
Gugler, R & J.Chris Jensen. (1987). Drugs other than H2-receptor antagonists as clinically important inhibitors of drug metabolism in vivo. Pharmacology & Therapeutics. 33(1). 133–137. 40 indexed citations
7.
Jensen, J.Chris & Morris D. Faiman. (1986). Disulfiram‐Ethanol Reaction in the Rat. 1. Blood Alcohol, Acetaldehyde, and Liver Aldehyde Dehydrogenase Relationships. Alcoholism Clinical and Experimental Research. 10(1). 45–49. 11 indexed citations
8.
Jensen, J.Chris & R Gugler. (1986). Inhibition of human liver cytochrome P‐450 by omeprazole.. British Journal of Clinical Pharmacology. 21(3). 328–330. 34 indexed citations
9.
Jensen, J.Chris & R Gugler. (1985). Interaction between metronidazole and drugs eliminated by oxidative metabolism. Clinical Pharmacology & Therapeutics. 37(4). 407–410. 18 indexed citations
10.
Gugler, R & J.Chris Jensen. (1985). Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro.. PubMed. 89(6). 1235–41. 144 indexed citations
11.
Gugler, R, et al.. (1985). Factors predicting the therapeutic outcome of duodenal ulcer treatment with H2-receptor antagonists. Journal of Molecular Medicine. 63(22). 1152–1159. 5 indexed citations
12.
Jensen, J.Chris & R Gugler. (1985). Cimetidine interaction with liver microsomes in vitro and in vivo. Biochemical Pharmacology. 34(12). 2141–2146. 30 indexed citations
13.
Gugler, R & J.Chris Jensen. (1985). Omeprazole inhibits oxidative drug metabolism. Gastroenterology. 89(6). 1235–1241. 136 indexed citations
14.
Gugler, R, et al.. (1984). The inhibition of drug metabolism by cimetidine in patients with liver cirrhosis. Journal of Molecular Medicine. 62(23). 1126–1131. 5 indexed citations
15.
Becker, Ulrik, et al.. (1984). Relapse Prevention of Duodenal Ulcers with Trimipramine, Cimetidine, or Placebo. Scandinavian Journal of Gastroenterology. 19(3). 405–410. 6 indexed citations
16.
Becker, Ulrik, et al.. (1983). Efficacy of Trimipramine and Cimetidine in the Treatment of Duodenal Ulcer. Scandinavian Journal of Gastroenterology. 18(1). 137–143. 14 indexed citations
17.
Jensen, J.Chris & R Gugler. (1983). Single- and multiple-dose metronidazole kinetics. Clinical Pharmacology & Therapeutics. 34(4). 481–487. 50 indexed citations
18.
Jensen, J.Chris & R Gugler. (1983). Sensitive high-performance liquid chromatographic method for the determination of metronidazole and metabolites. Journal of Chromatography B Biomedical Sciences and Applications. 277. 381–384. 26 indexed citations
19.
Jensen, J.Chris, et al.. (1982). Elimination characteristics of disulfiram over time in five alcoholic volunteers: a preliminary study. American Journal of Psychiatry. 139(12). 1596–1598. 8 indexed citations
20.
Jensen, J.Chris & Morris D. Faiman. (1980). Determination of disulfiram and metabolites from biological fluids by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 181(3-4). 407–416. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by X.-J. Zhao Breakdown of academic impact, for papers by H Laufen Breakdown of academic impact, for papers by Geoffrey Warhurst Breakdown of academic impact, for papers by F A deLuna Breakdown of academic impact, for papers by Keith Hoffmaster Breakdown of academic impact, for papers by Sou-Yie Chu Breakdown of academic impact, for papers by Hugues Chanteux Breakdown of academic impact, for papers by Steven R. Cox Breakdown of academic impact, for papers by Niklas Finnström Breakdown of academic impact, for papers by R A Yeates
Rankless by CCL
2026